ANIP vs COO: fair value comparison
ANI Pharmaceuticals, Inc. and The Cooper Companies, Inc. · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, ANIP currently sits closer to the top of our discount ranking. COO carries the stronger quality grade.
| ANIP | COO | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $80.06 | $69.59 |
| 12-month range | $75.22–$94.06 | $60.19–$83.92 |
| Sector rank | #12 of 113 Healthcare | #16 of 113 Healthcare |
| Quality grade | C- | A |
| Momentum grade | — | A |
| Leverage | Moderate | Low |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: ANIP fair value analysis · COO fair value analysis